<DOC>
	<DOCNO>NCT00444834</DOCNO>
	<brief_summary>The purpose study compare efficacy EgaletÂ® control release formulation immediate release Carvedilol tablet .</brief_summary>
	<brief_title>A Study Controlled-Release Carvedilol Compared Immediate-Release Carvedilol Patients With Primary Hypertension</brief_title>
	<detailed_description />
	<mesh_term>Hypertension</mesh_term>
	<mesh_term>Carvedilol</mesh_term>
	<criteria>Have diagnosis mild moderate primary hypertension Be able tolerate 2 week washout phase follow 2 week Placebo run phase Be minimum 18 year age Be intolerant alfa betablockers Have secondary cause hypertension Be take two antihypertensive medication</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2016</verification_date>
</DOC>